Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Platz

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Tumori|December 31, 1984
An unusual case of multiple malignancy in an adultO Weis Bjerrum, S Gjedde, K Bendtzen, et al.
Human Immunology|June 1, 1989
Alloactivated HLA class II-positive T-cell lines induce IL-2 reactivity but lack accessory cell function in mixed leukocyte cultureN Odum, E Dickmeiss, B Hofmann, et al.
American Journal of Human Genetics|March 1, 1983
Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA systemN E Morton, A Green, T Dunsworth, et al.
Hepatology (Baltimore, Md.)|December 24, 1998
Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replicationT Berg, A R Müller, K P Platz, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1977
Transfer factor treatment of multiple sclerosis. A pilot studyC Jersild, P Platz, A Svejgaard, et al.
Tissue Antigens|January 1, 1986
An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2BN Odum, R Hartzman, B K Jakobsen, et al.
Annals of Surgery|July 2, 2003
IL-10 increases tissue injury after selective intestinal ischemia/reperfusionNatascha C Nüssler, Andrea R Müller, Hans Weidenbach, et al.
Tissue Antigens|November 1, 1987
HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute graft versus host diseaseN Odum, P Platz, B K Jakobsen, et al.
Progress in Clinical and Biological Research|January 1, 1982
Workshop on genetics of diabetesJ I Rotter, P Platz, C E Anderson, et al.
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Tumori|December 31, 1984
An unusual case of multiple malignancy in an adultO Weis Bjerrum, S Gjedde, K Bendtzen, et al.
Human Immunology|June 1, 1989
Alloactivated HLA class II-positive T-cell lines induce IL-2 reactivity but lack accessory cell function in mixed leukocyte cultureN Odum, E Dickmeiss, B Hofmann, et al.
American Journal of Human Genetics|March 1, 1983
Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA systemN E Morton, A Green, T Dunsworth, et al.
Hepatology (Baltimore, Md.)|December 24, 1998
Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replicationT Berg, A R Müller, K P Platz, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1977
Transfer factor treatment of multiple sclerosis. A pilot studyC Jersild, P Platz, A Svejgaard, et al.
Tissue Antigens|January 1, 1986
An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2BN Odum, R Hartzman, B K Jakobsen, et al.
Annals of Surgery|July 2, 2003
IL-10 increases tissue injury after selective intestinal ischemia/reperfusionNatascha C Nüssler, Andrea R Müller, Hans Weidenbach, et al.
Tissue Antigens|November 1, 1987
HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute graft versus host diseaseN Odum, P Platz, B K Jakobsen, et al.
Progress in Clinical and Biological Research|January 1, 1982
Workshop on genetics of diabetesJ I Rotter, P Platz, C E Anderson, et al.
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Pageof 22